<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Boyden SE</submitter><funding>CCR NIH HHS</funding><funding>Intramural NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>656-63</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4782791</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>374(7)</volume><pubmed_abstract>Patients with autosomal dominant vibratory urticaria have localized hives and systemic manifestations in response to dermal vibration, with coincident degranulation of mast cells and increased histamine levels in serum. We identified a previously unknown missense substitution in ADGRE2 (also known as EMR2), which was predicted to result in the replacement of cysteine with tyrosine at amino acid position 492 (p.C492Y), as the only nonsynonymous variant cosegregating with vibratory urticaria in two large kindreds. The ADGRE2 receptor undergoes autocatalytic cleavage, producing an extracellular subunit that noncovalently binds a transmembrane subunit. We showed that the variant probably destabilizes an autoinhibitory subunit interaction, sensitizing mast cells to IgE-independent vibration-ind</pubmed_abstract><journal>The New England journal of medicine</journal><pubmed_title>Vibratory Urticaria Associated with a Missense Variant in ADGRE2.</pubmed_title><pmcid>PMC4782791</pmcid><funding_grant_id>HHSN261200800001E</funding_grant_id><funding_grant_id>HHSN261200800001C</funding_grant_id><funding_grant_id>ZIA AI001091</funding_grant_id><pubmed_authors>Olivera A</pubmed_authors><pubmed_authors>Kastner DL</pubmed_authors><pubmed_authors>Eisch AR</pubmed_authors><pubmed_authors>Metcalfe DD</pubmed_authors><pubmed_authors>Chouery E</pubmed_authors><pubmed_authors>Medlej-Hashim M</pubmed_authors><pubmed_authors>Young ML</pubmed_authors><pubmed_authors>Kidd KK</pubmed_authors><pubmed_authors>Boyden SE</pubmed_authors><pubmed_authors>Scott LM</pubmed_authors><pubmed_authors>Cruse G</pubmed_authors><pubmed_authors>Komarow HD</pubmed_authors><pubmed_authors>Long RD</pubmed_authors><pubmed_authors>Desai A</pubmed_authors><pubmed_authors>Bolan HC</pubmed_authors><pubmed_authors>Lee CC</pubmed_authors><pubmed_authors>Satorius CL</pubmed_authors><pubmed_authors>Mullikin JC</pubmed_authors><pubmed_authors>Pakstis AJ</pubmed_authors><pubmed_authors>Megarbane A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Vibratory Urticaria Associated with a Missense Variant in ADGRE2.</name><description>Patients with autosomal dominant vibratory urticaria have localized hives and systemic manifestations in response to dermal vibration, with coincident degranulation of mast cells and increased histamine levels in serum. We identified a previously unknown missense substitution in ADGRE2 (also known as EMR2), which was predicted to result in the replacement of cysteine with tyrosine at amino acid position 492 (p.C492Y), as the only nonsynonymous variant cosegregating with vibratory urticaria in two large kindreds. The ADGRE2 receptor undergoes autocatalytic cleavage, producing an extracellular subunit that noncovalently binds a transmembrane subunit. We showed that the variant probably destabilizes an autoinhibitory subunit interaction, sensitizing mast cells to IgE-independent vibration-ind</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Feb</publication><modification>2026-05-04T13:46:51.841Z</modification><creation>2019-03-27T02:10:40Z</creation></dates><accession>S-EPMC4782791</accession><cross_references><pubmed>26841242</pubmed><doi>10.1056/NEJMoa1500611</doi><doi>10.1056/nejmoa1500611</doi></cross_references></HashMap>